Acrux Limited (AU:ACR) has released an update.
Acrux Limited, a specialty pharmaceutical company, recently showcased their expertise and products at the 18th Bioshares Biotech Summit. With a focus on the development and commercialization of topically applied pharmaceutical products, Acrux has a history of successfully marketing products, particularly in the U.S., and is exploring collaboration and partnership opportunities. They emphasize their strong background and facilities for bringing affordable topical generic products to market.
For further insights into AU:ACR stock, check out TipRanks’ Stock Analysis page.
